share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill

SEC ·  Jun 12, 2023 11:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more